Cargando…

Frequency of serum tumour marker monitoring.

Detalles Bibliográficos
Autor principal:	Colls, B. M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1991
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972358/ https://www.ncbi.nlm.nih.gov/pubmed/1850614

Ejemplares similares

Surveillance or etoposide-containing combination chemotherapy for stage I non-seminomatous germ cell tumours of the testis (NSGCTT)
por: Colls, B. M.
Publicado: (1994)

Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours.
por: Seckl, M. J., et al.
Publicado: (1990)

Adriamycin cardiotoxicity monitoring by radionuclide scan.
por: Robinson, B. A., et al.
Publicado: (1983)

Increased frequency of the S allele of the L-myc oncogene in non-Hodgkin's lymphoma.
por: Crossen, P. E., et al.
Publicado: (1994)

Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2019)

Serum proteins as tumour markers for breast cancer.
por: Mattison, P., et al.
Publicado: (1981)

Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy
por: Tuxen, M K, et al.
Publicado: (2001)

Value of monitoring serum immunoglobulins questioned.
por: Greenberg, G N, et al.
Publicado: (1994)

The relevance of RT–PCR markers for metastatic tumour cell detection
por: Chechlińska, M, et al.
Publicado: (2006)

How to define a cut-off value of tumour markers in haemodialysis patients?
por: Mercadal, Lucile, et al.
Publicado: (2009)

Role of tumour markers in monitoring epithelial ovarian cancer
por: Meyer, T, et al.
Publicado: (2000)

Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma.
por: van der Schouw, Y. T., et al.
Publicado: (1992)

RE: Serum viral markers in Iranian patients with congenital bleeding disorder
por: Alavian, Seyed M., et al.
Publicado: (2009)

Low-frequency monitoring for community clozapine initiations: A comparative study relative to standard frequency assessments
por: Mizuno, Yuya, et al.
Publicado: (2023)

Neuron-specific enolase--a serum tumour marker in seminoma?
por: Fosså, S. D., et al.
Publicado: (1992)

Serum Metallothioneins in Childhood Tumours—A Potential Prognostic Marker
por: Kruseova, Jarmila, et al.
Publicado: (2013)

Serum tumour markers in carcinoma of the uterine cervix and outcome following radiotherapy.
por: Sproston, A. R., et al.
Publicado: (1995)

The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer.
por: Lindmark, G., et al.
Publicado: (1995)

Faecal tumour pyruvate kinase M2: not a good marker for the detection of colorectal adenomas
por: Shastri, Y M, et al.
Publicado: (2008)

On the clonality of tumours.
por: Woodruff, M. F., et al.
Publicado: (1985)

Low Frequency Vibration Visual Monitoring System Based on Multi-Modal 3DCNN-ConvLSTM
por: Alimasi, Alimina, et al.
Publicado: (2020)

Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer.
por: Johnson, P. W., et al.
Publicado: (1993)

Serum thyroglobulin as a preclinical tumour marker in subgroups of thyroid cancer.
por: Thoresen, S. O., et al.
Publicado: (1988)

A serum factor with potential as a tumour marker in malignant lymphoma.
por: Begent, R. H., et al.
Publicado: (1980)

Cellular fibronectin in serum and plasma: a potential new tumour marker?
por: Ylätupa, S., et al.
Publicado: (1995)

Alteration of serum markers in COVID‐19 and implications on mortality
por: Liu, Dan, et al.
Publicado: (2020)

Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma
por: Thomas, E, et al.
Publicado: (2005)

Reply to Alavian and Tabatabaei: Serum viral markers in Iranian patients with congenital bleeding disorder
por: Abdollahi, Alireza
Publicado: (2009)

Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer.
por: Haglund, C., et al.
Publicado: (1986)

Monoclonal antibody assay of serum placental alkaline phosphatase in the monitoring of testicular tumours.
por: Epenetos, A. A., et al.
Publicado: (1985)

'Tumour volume'.
por: Clelland, C. A.
Publicado: (1997)

MESOTHELIOMA V/S ADENOCARCINOMA OF LUNG DO SERUM MARKERS HELP?
por: Gupta, Neeraj
Publicado: (2008)

Serum inflammatory markers in the diagnosis and assessment of Crohn’s disease activity
por: Słowińska-Solnica, Krystyna, et al.
Publicado: (2021)

Clinical evaluation of serum tumour marker CA 242 in non-small cell lung cancer.
por: Pujol, J. L., et al.
Publicado: (1993)

Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia
por: Zhou, Xinping, et al.
Publicado: (2023)

Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.
por: Pasanen, P. A., et al.
Publicado: (1992)

Reply: Faecal tumour pyruvate kinase M2: not a good marker for detection of colorectal adenomas
por: Haug, U, et al.
Publicado: (2008)

Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw
por: Vincenzi, Bruno, et al.
Publicado: (2012)

Serum calprotectin: A marker for early diagnosis of diabetic peripheral neuropathy
por: Balasundaram, Mahesh Kumar, et al.
Publicado: (2021)

Retrospective Longitudinal Monitoring of Multiple Myeloma Patients by Mass Spectrometry Using Archived Serum Protein Electrophoresis Gels and De Novo Sequence Analysis
por: Noori, Somayya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p8p4424tr5ve9hbl6ulg5g1vlm